13 - 15 November, 2018 | DoubleTree by Hilton Hotel London - Victoria, London, United Kingdom

Meet the Speakers

Early 2018 Speakers Include:


Lior Raviv
Lior Raviv
Vice President Of Development
Pluristem Therapeutics
Fabio Fachin
Fabio Fachin
VP, Cell Therapy Manufacturing
Torque Therapeutics
Carol Knevelman
Carol Knevelman
Head of Process Development
Oxford BioMedica
Robert Piperno
Robert Piperno
Director Cell and Gene Therapy QA
GSK
Nina Kotsopoulou
Nina Kotsopoulou
Head, Process Development
Autolus
Robert Allen
Robert Allen
Senior Director, Immunotherapy Programme
Asterias Biotherapeutics
Peter Wernet
Peter Wernet
CEO
RheinCell Therapeutics GmbH
Eugenio Macchiarulo
Eugenio Macchiarulo
Vector Development Associate Director
Adaptimmune Ltd
Sheuli Porkess
Sheuli Porkess
Deputy Chief Scientific Officer
ABPI
Benoît Champluvier
Benoît Champluvier
Chief Technology and Manufacturing Officer
Bone Therapeutics
Professor Brendon Noble
Professor Brendon Noble
CSO & Director of Strategy
UK Stem Cell Foundation, The Royal Institution of Great Britain
Arjan Roozen
Arjan Roozen
CTO and Head of Manufacturing
Zelluna Immunotherapy
Andrew Finnerty
Andrew Finnerty
General Manager
Centre for Cell Manufacture Ireland (CCMI)
Donna McLaren
Donna McLaren
Process Science Manager – CMC
ReNeuron
Omar Ali
Omar Ali
Visiting Lecturer Value Based Pricing and Former Advisor
University of Portsmouth and NICE
Mark Woodyer
Mark Woodyer
Technical Lead, Manufacturing Sciences & Technology
Oxford Biomedica
Katy Spink
Katy Spink
COO and Managing Partner
Dark Horse Consulting
Ales Strancar
Ales Strancar
Managing Director
BIA Separations
Yen Choo
Yen Choo
CEO and Executive Chairman
Plasticell and Progenitor Labs
Simon Briggs
Simon Briggs
Product Steward, Cell and Gene Therapy Unit - Kymriah, C&G Technical Operations
Novartis - Pending Final Confirmation